Q2 2025 Holdings
Filed 2025-08-14 | 72 holdings | $1.9B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Arcellx Inc(ACLX) | COMMON STOCK | 03940C100 | $181.1M | 2,750,000 | 9.5% |
| Jazz Pharmaceuticals PLC(JAZZ) | SHS USD | G50871105 | $127.3M | 1,200,000 | 6.7% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $98.3M | 2,975,000 | 5.2% |
| Nuvalent Inc(NUVL) | COM | 670703107 | $82.0M | 1,075,000 | 4.3% |
| Vera Therapeutics Inc(VERA) | CL A | 92337R101 | $73.0M | 3,100,000 | 3.8% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $68.2M | 11,900,000 | 3.6% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $62.6M | 2,000,000 | 3.3% |
| Dianthus Therapeutics Inc(DNTH) | COM | 252828108 | $59.6M | 3,200,000 | 3.1% |
| Scholar Rock Holding Corp(SRRK) | COM | 80706P103 | $53.1M | 1,500,000 | 2.8% |
| KalVista Pharmaceuticals Inc(KALV) | COM | 483497103 | $52.9M | 4,675,000 | 2.8% |
| GE HealthCare Technologies Inc(GEHC) | COMMON STOCK | 36266G107 | $51.8M | 700,000 | 2.7% |
| uniQure NV(QURE) | SHS | N90064101 | $51.6M | 3,700,000 | 2.7% |
| Bicara Therapeutics Inc(BCAX) | COM | 055477103 | $46.5M | 5,000,000 | 2.4% |
| Alcon AG(ALC) | ORD SHS | H01301128 | $46.3M | 525,000 | 2.4% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $44.1M | 1,200,000 | 2.3% |
| Crinetics Pharmaceuticals Inc(CRNX) | COM | 22663K107 | $43.1M | 1,500,000 | 2.3% |
| Exact Sciences Corp(EXAS) | COM | 30063P105 | $37.2M | 700,000 | 2.0% |
| Celldex Therapeutics Inc(CLDX) | COM NEW | 15117B202 | $35.6M | 1,750,000 | 1.9% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $34.5M | 200,000 | 1.8% |
| Immatics NV(IMTX) | SHS | N44445109 | $33.6M | 6,250,000 | 1.8% |
| Geron Corp(GERN) | COM | 374163103 | $33.5M | 23,775,000 | 1.8% |
| Globus Medical Inc(GMED) | CL A | 379577208 | $29.5M | 500,000 | 1.6% |
| BioMarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $27.5M | 500,000 | 1.4% |
| MoonLake Immunotherapeutics(MLTX) | CLASS A ORD | 61559X104 | $26.0M | 550,000 | 1.4% |
| Tyra Biosciences Inc(TYRA) | COM | 90240B106 | $25.4M | 2,655,000 | 1.3% |
| Savara Inc(SVRA) | COM | 805111101 | $25.1M | 11,015,000 | 1.3% |
| Cooper Cos Inc(COO) | COM | 216648501 | $24.9M | 350,000 | 1.3% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $24.9M | 1,200,000 | 1.3% |
| Cidara Therapeutics Inc(CDTX) | COM NEW | 171757206 | $24.4M | 500,000 | 1.3% |
| Astria Therapeutics Inc(CATBUSD) | COM | 04635X102 | $24.2M | 4,522,000 | 1.3% |
| Abbott Laboratories(ABT) | COM | 002824100 | $23.8M | 175,000 | 1.3% |
| Edwards Lifesciences Corp(EW) | COM | 28176E108 | $23.5M | 300,000 | 1.2% |
| Nurix Therapeutics Inc(NRIX) | COM | 67080M103 | $22.8M | 2,000,000 | 1.2% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $22.1M | 3,080,000 | 1.2% |
| Bruker Corp(BRKR) | COM | 116794108 | $20.6M | 500,000 | 1.1% |
| Ionis Pharmaceuticals Inc(IONS) | COM | 462222100 | $19.8M | 500,000 | 1.0% |
| Day One Biopharmaceuticals Inc(DAWN) | COM | 23954D109 | $19.5M | 3,000,000 | 1.0% |
| Medtronic PLC(MDT) | SHS | G5960L103 | $17.0M | 195,000 | 0.9% |
| Perrigo Co PLC(PRGO) | SHS | G97822103 | $16.7M | 625,000 | 0.9% |
| Zymeworks Inc(ZYME) | COM | 98985Y108 | $14.4M | 1,150,000 | 0.8% |
| Black Diamond Therapeutics Inc(BDTX) | COM | 09203E105 | $13.9M | 5,600,000 | 0.7% |
| Lexeo Therapeutics Inc(LXEO) | COM | 52886X107 | $13.0M | 3,228,161 | 0.7% |
| Nyxoah SA(NYXH) | SHS | B6S7WD106 | $10.5M | 1,402,002 | 0.6% |
| Thermo Fisher Scientific Inc(TMO) | COM | 883556102 | $10.1M | 25,000 | 0.5% |
| Danaher Corp(DHR) | COM | 235851102 | $9.9M | 50,000 | 0.5% |
| Beta Bionics Inc(BBNX) | COM | 08659B102 | $8.0M | 550,000 | 0.4% |
| Disc Medicine Inc(IRON) | COM | 254604101 | $7.4M | 140,000 | 0.4% |
| Solid Biosciences Inc(SLDB) | COM NEW | 83422E204 | $7.3M | 1,505,000 | 0.4% |
| Taysha Gene Therapies Inc(TSHA) | COM SHS | 877619106 | $6.9M | 3,000,000 | 0.4% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $6.9M | 727,500 | 0.4% |